Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer?

Archives of Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 4, 1999, Pages 379-382

  Cooney, Timothy R ^a   Poulsen, Michael G ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b Queensland Radium Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; FEMALE; FOLLOW UP; HEAD CANCER; HUMAN; MALE; NECK CANCER; RECURRENCE RISK; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0032900492     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.125.4.379     Document Type: Article

References (16)

1. Schwartz L, Ozsahin M, Zhang G, et al. Synchronous and metachronous head and neck carcinomas. Cancer. 1994;74:1933-1938.
2. Sturgis E, Miller R. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol. 1995;104:946-954.
3. Vikram B, Strong EW, Shah JP, Spiro R. Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg. 1984;6:734-737.
4. Tepperman BS, Fitzpatrick PJ. Second respiratory and upper digestive tract cancer after oral cancer. Lancet 1981;62:547-549.
5. Davidson J, Briant D, Gullane P, Keane T, Rawlinson E. The role of surgery following radiotherapy failure for advanced laryngopharyngeal cancer: a prospective study. Arch Otolaryngol Head Neck Surg. 1994;120:269-276.
6. Harwood J. Cancer of the larynx. J Otolaryngol. 1982;11(suppl):3-21.
7. Bryant GP, Poulsen MG, Tripcony L, Dickie GJ. Treatment decisions in T3NOMO glottic carcinoma. Int J Radiat Oncol Biol Phys. 1995;31:285-293.
8. Union Internationale Contre le Cancer. Tumour Classification. 4th ed. 2nd rev. Geneva, Switzerland: Union Internationale Contre le Cancer; 1992:1-28.
9. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer. 1932;16:1358-1414.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1953;53:457-481.
11. Cochrane JPS, Williams JT, Faber RG, Slack WW. Value of outpatient follow-up after curative surgery for carcinoma of the large bowel. BMJ. 1980;280: 593-595.
12. Dewar JR, Kerr GR. Value of routine follow-up of women treated for early carcinoma of the breast. BMJ. 1985;291:1464-1467.
13. Queisser W, Maurer U, Schmidt H. Efficacy of German regional follow-up program of 5411 cancer patients. J Cancer Res Clin Oncol. 1990;116(suppl, pt 1): 206. Abstract A2.23102.
14. Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 1992;28: 426-430.
15. de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity: does it make sense?. Arch Otolaryngol Head Neck Surg. 1994;120:934-939.
16. Stalpers LJ, van Vierzen PB, Brouns JJ, et al. The role of yearly chest radiography in the early detection of lung cancer following oral cancer. Int J Oral Maxillofac Surg. 1989;18:99-103.